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The candidate gene approach in tracking the underly­
ing cause of a number of genetic skin disorders .. has 
proved' remarkably effective over the past few years. 
mectron microscopy has had a unique role in identify­
ing morphologic abnormalities of various fibers, fi­
brils, and filaments, and helping to localize biochemi­
cal constituents to these structures. Nowhere is this 
approach more strongly demonstrated than in its ap-
T he highly complex organization of the dermal-epi­dermal junction or basement membrane zone (BMZ) became evident largely as a result of the study of ul­trathin sections of skin using transmission electron microscopy. Efforts to extract and isolate components 
of the BMZ for biochemical analysis have met with limited success. 
However, studies on intact or chemically separatedBMZ by immu­
nohistochemistry have proved useful in partially localizing cillfer­
ent antigens related to key structures that are thought to have a role 
in attachment between the epidermis and dermis. Immunoelectron 
microscopy, especially with colloidal gold labelling, has enabled 
more precise antigen localization than was possible previously. 
This article will illustrate how a morphologic approach using 
conventional transmission electron microscopy in combination 
with immunofluorescence and immunoelectron microscopy has 
been able to provide clues to candidate proteins and genes in herit­
able disorders of the BMZ, as exemplified by two forms of epider­
molysis bullosa (BB). 
ULTRASTRUCTURE AND MOLECULAR 
CONSTITUENTS OF NORMAL DERMAL-EPIDERMAL 
JUNCTION 
The separation of the basement membrane into distinct layers, the 
lamina lucida, lamina densa, and lamina fibroreticularis, is question­
able and probably imposes unnatural restrictions on the concept of 
close structural and functional interactions between the various 
BMZ constituents [1] (Fig 1). Nevertheless, these boundaries, arti­
ficial or real, are highly reproducible in conventional electron mi­
croscopic images and provide a spatial relationship between identi­
fiable structures and their associated molecules. 
Hemidesmosomes are distributed on the basal plasma membrane 
of basal keratinocytes. They are most easily recognized as compris­
ing regular densities or plaques that can be single or composite, 
having outer and inner (cytoplasmic) components, the latter serving 
as interaction points with keratin intermediate filaments [2]. Tra-
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versing the lamina lucida are fine filamentous structures, the an­
choring filaments, that appear denser and more conspicuous in asso­
ciation with hemidesmosomes. The sub-basal dense plate lies under 
and parallel to the hemidesmosome outer plaque within the u�:: 
part of the lamina lucida. This structure appears as a continuous . 
line or density in electron micrographs of up to -40,OOOX, but in 
higher magnification views of skin processed using tannic acid the 
dense plate appears to consist of a linear array resembling a string of 
square to circular beads. Anchoring fibrils are curvilinear structures 
of about 800 nm in length [3] with fan-shaped or whisk-like ends 
and centrosymmetrical banding. One end is associated with the 
lamina densa and the other appears to terminate in the dermal ma­
trix or insert into small amorphous bodies, the anchoring plaques 
[3]. Anchoring plaques are not always recognized in conventionally 
prepared ultrathin sections of skin and may become more visible, as 
can anchoring fibrils, under certain conditions, such as processing of 
fresh unfixed tissue for pre-embedding immunogold electron mi­
croscopy (Eady, Shimizu, and McGrath, unpublished). We have no 
explanation yet for these observations , but suspect that removal of 
water soluble material might somehow render these structures more 
accessible to uranyl or lead salts used in staining for electron micros­
copy. 
Anchoring fibrils are unevenly distributed among body regions 
and their numbers can vary by as much as 0.3 to 2.2 per J.llt1 oflamina 
densa [4]. They form a complex network in the superficial dermis 
that may strengthen and stabilize the attachment of the basement 
membrane to the underlying dermis [5]. 
Elastic microfibrils containing fibrillin [6] also appear to link up 
with the underside of the lamina densa and project, often as bundles, 
into the dermis where they associate with elastic fibers in the reticu­
lar layer. These structures are less numerous than anchoring fibrils 
and tend to decline with age [4]. Micro-thread - like material con­
taining a partially characterized protein, linkin,* is also found 
among collagen fibrils in the superficial dermis. 
• Briggaman RA, Yoshiike T. Woodley DT. Gammon WR, Cronce OJ: 
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0022-202X/94/S07.00 Copyright © 1994 by The Society for Investigative Dermatology, Inc. 
138 
14S EADY E.T AL 
Figure 1. Transmission electron micrograph of the dermal-epider­
mal junction beneath a basal keratiDocyte (K). Tonofilaments (tf) 
course in bundles through the cytoplasm to link with the inner plaque (ip) of 
hemidesmosomes (hd). The outer plaque (op) is associated with the plasma 
membrane, just above the sub-basal dense plate (dp) and anchoring filaments 
(afl), within the lamina lucida (11). Anchoring fibrils (afb) project into the 
dermis (D) from the lamina densa (ld). Bar, 0.5 p.m. 
Ontogeny During early embryonic development the dermal­
epidermal junction is flat, and contains an identifiable lamina lucida 
and lamina densa [7,8]. Hemidesmosome plaques with associated 
filaments can be identified by 9 weeks estimated gestational age and 
anchoring filaments and fibrils start to appear at about the same 
time. Anchoring fibrils are thin and wispy and the characteristic 
banding may not be apparent at first [8]. 
Macromolecular Constituents The localization of various 
constituent molecules as determined by immunocytochemistry 
(Fig 2) shows that hemidesmosomes contain bullous pemphigoid 
(BP) antigens of230 kD [9] and 180kD [10], the a6p4 integrin (Fig 
. 3) [11,12], and other less well-defined antigens recognized by 
monoclonal antibodies [13,14]' 
The BP antigens recognized by patients' sera have been localized 
mainly to the hemidesmosomal plaque [15,16] with a smaller, yet 
significant, extracellular binding [17]. Quantitative immunogold 
studies showed that the 230-kD BP antigen had a peak concentra­
tion oflabeling 75 nm inside the cell, corresponding roughly to the 
site of interaction with keratin filaments, whereas the 180-kD anti­
gen was cell-surface related [18]. 
Laminin is the major lamina lucida component, but it also occurs 
in the lamina densa. Concentrated mainly under hemidesmosome 
plaques (where anchoring filaments are especially dense) are the 
proteins BM600/nicein, recognized by GB3 monoclonal antibody 
[19-21] (Fig 4B). kalinin [22], and epiligrin [23], all of which are 
synthesized by keratinocytes: nicein and kalinin have trimeric 
structures and are now considered to be very similar if not identical 
to each other [24] and also to epiligrin [25]. Epiligrin has been 
shown to be a ligand for the integrin a3pl and is associated in vitro 
with hemidesmosome-like structures and a6p4 [26]. 19-DEJ-1 
monoclonal antibody binds to proteoglycan in the mid-lamina lu­
cida [27] (Fig 4A). slightly higher in location compared with the 
localization of various nicein components [21]. K-laminin is a novel 
laminin variant that shares similarities in structure and localization 
with kalinin [28]. 
Concentrated chiefly within the lamina densa are type IV colla­
gen, heparan sulfate proteoglycan, nidogen/entactin. chondroitin-
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Figure 2. Diagrammatic representation of molecalar composition 
of basement membrane zone (not to scale). LL, lamina lucida; LD, 
lamina densa; C-6-S-PG, chondroitin-6-sulfate proteoglycan; HSPG, hepa. 
ran sulfate proteoglycan. 
6-sulfate proteoglycan, and various other less well-established com­
ponents (see [29,30] for review). The main, if not only, constituent 
of anchoring fibrils is type VII collagen [3,31]. Anchoring fibrils are 
formed by lateral aggregation of type VII collagen dimers, contain­
ing an alpha-helical collagenous central region and large globular 
non-collagenous NC-1 domains at either end [3] (Fig 7A.). Early 
clues relating anchoring fibrils to type VII collagen were based on 
their ultrastructural resemblance to crystallites oflong-spacing col­
lagen [32]. The NC-l domain type VII collagen is also the target of 
autoantibodies in the immunobullous disease, epidermolysis bullosa 
acquisita [33] . 
Figure 3. Immunogold laheling of integrin fJ4 in dermal-epidermal 
junction. The anti-fJ4 antibody 4S0-11A was used in a three-layer tech­
nique on a Lowicryl KI1M section of normal skin. The 5-nm gold particles 
are clustered over hemidesmosome plaques, in a basal keratinocyce (K). The 
lamina densa (ld) is weakly stained. Bar, 0.25 p.m. 
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Figure 4. Immunoelectron micrographs of 19-DEJ-l (A) and GB3 
(anti-nicein) (B) labeling in normal skin. The tissue was first incubated 
with GB3 or 19-DEJ-l, followed by an anti-mouse IgG conjugated to Inm 
colloidal gold that was enlarged by silver enhancement. Both antibodies 
localize to hemidesmosome/anchoring filament-related epitopes. Insets, A, 
19-DEJ-l in mid-lamina lucida; B, GB3 is slightly lower, at the interface 
with the lamina densa. Bar, 1 p.m. 
DYSTROPHIC EPIDERMOLYSIS BULLOSA, 
ANCHORING FIBRILS, AND TYPE VII COLLAGEN 
Dystrophic EB is transmitted in autosomal dominant or recessive 
forms. The degree of phenotypic expression can be variable, and at 
least 10 clinical sub-types have been described [34]. All forms are 
characterized by a particular type of scarring and nail dystrophy. 
The most severe form is an autosomal recessive generalized disease, 
associated with growth retardation, poor nutrition, anemia, muti­
lating contractures, especially of the hands, pseudosydactyly, 
esophageal stenosis, squamous cell carcinoma, and shortened life 
span. Milder forms of dystrophic EB may show little or nothing 
more than nail abnormalities. The mechanisms accounting for these 
very divergent manifestations are not yet known; however, we do 
know that all forms of dystrophic EB have at least two features in 
common: a level of blistering beneath the lamina densa [35] and an 
abnormality of anchoring fibrils. Anchoring fibrils may be absent or 
unrecognizable, reduced in number (Fig 5), malformed, or other­
wise structurally altered [36-39]. 
During the 1980s anchoring fibrils were shown to contain type 
VII collagen (see above, [3,31]) and immunohistochemical and im­
munoblotting studies using antibodies to type VII collagen pro­
vided the first biochemical evidence for an abnormality of this 
newly recognized collagen in the skin of patients with recessive 
forms of the disease [40-43]. Other studies using a variety of 
monoclonal antibodies, including AF-l and AF-2 [44] and KF-l 
[45], also showed reduced staining in the lamina densa or anchoring 
fibrils in dystrophic EB skin, suggesting an underlying biochemical 
abnormality affecting this part of the BMZ even though the epi­
topes had not been characterized. 
The combination of immuno(histo)chemistry and electron mi-
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Figure S. Mean anchoring fibril counts in dystrophic EB, in com­
parison with controls. DDEB, dominant dystrophic EB; RDEB, recessive 
dystrophic EB. (Derived from [39], previously published in [29], and repro­
duced with permission.) 
croscopy pointed to different abnormalities of anchoring fibrils and 
type VII collagen in the inverse form of recessive dystrophic EB [46] 
and in cases of dystrophic EB, mainly of dominant inheritance, 
showing intracellular deposits of type VII collagen [47,48] (Fig 6). 
These observations raise interesting questions about the synthesis 
and secretion of the protein. Another study by our own group [49] 
assessing type VII collagen expression in relation to anchoring fi­
brils at the dermal-epidermal junction illustrated the diversity of 
morphologic changes that can occur in anchoring fibrils of patients 
with different forms of dystrophic EB (Fig 7). The study also high­
lighted the difficulty in identifying anchoring fibrils, and especially 
structurally abnormal fibrils, in conventional ultrathin sections, and 
also showed the range in size (width measurements) of fibrils in a 
few patients. The same approach could be used to examine the skin 
of heterozygotes for the recessive forms of dystrophic EB, who tend 
to have fewer anchoring fibrils than normal [50]. 
JUNCTIONAL EPIDERMOLYSIS BULLOSA, 
HEMIDESMOSOMES, ANCHORING FILAMENTS, AND 
NICEIN/KALININ/EPILIGRIN 
Junctional EB, an autosomal recessive disorder, is best known for its 
most common and extremely severe Herlitz or letalis form [34]. 
Less severe forms may also occur. The level of blistering is consist-
Figure 6. TEM of basal keratinocyte showing retention of type VB 
collagen. The abnormal amorphous and filamentous material is present in 
membrane-bounded vacuoles near the nucleus (n). Arrow, dermal-epidermal 
junction. Bar, 0.7 p.m. 
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Figure 7. Immunogold silver labeling of the NC·l part of type vn collagen using LH7.2 monoclonal antibody [43]. Note variation in 
morphology oflabeled anchoring fibrils in A, normal skin, B, dominant dystrophic ED skin, C, andD, recessive dystrophic ED including milder, localized (C) 
and severe generalized (D) forms. Bar, 0.32 I'm. First published in [50) and reproduced with permission. 
endy within the lamina lucida of the dennal.epidermal junction 
(Fig 8). A number of studies have shown that hemidesmosomes are 
sparse and small [51- 53]. A morphometric assessment showed vari­
able ultrastructural changes. In the more severe fonns of the disease, 
the hemidesmosomes tended to be decreased in number with poorly 
formed sub-basal plates, whereas these structures could appear nor­
mal, especially in patients with less severe disease [53] (Fig 9). 
The evidence for a hemidesmosome disorder in vivo was 
Figure 8. TEM of skin from patient with lethaljunctional ED. A split 
is present at the level of the lamina lucida (ll), beneath the basal keratinocyte 
(K) and above the lamina densa (ld). Normal hemidesmosome plaques are 
absent along the kc:ratinocyte plasma membrane. Bar, 0.7 I'm. 
strengthened by in vitro studies showing that keratinocytes from 
several junctional EB patients had abnormal hemidesmosome-like 
structures [54] . In another study, keratinocytes from patients with a 
non-lethal phenotype showed an abnormality of the actin cytoskel­
eton with associated focal contacts [55], rerhaps suggesting a differ­
ent primary abnormality in this form 0 EB. 
In common with the developments in dystrophic EB, casting the 
spotlight on anchoring fibrils, immunohistochemistry has also had 
an important part to play in junctional EB. A rabbit antiserum (AA3 
or 6/12) raised against an extract of human amnion and recognizing 
a 37-kD antigen localized to the lamina lucida [56] exhibited re­
duced immunofluorescence staining in the skin of patients with 
junctional EB [57]. A little later, the monoclonal antibody GB3 was 
found to give even more clear-cut staining in junctional EB, with 
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Figure 9. Hemidesmosome population density in different forms of 
junctional ED. Tops of bars, mean counts; imide bars, percentage ofhemides­
mosomes with sub-basal dense plates. Extrapolated &om [53]. published in 
[29) and reproduced with permission. 
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the letalis specimens consistently showing absent or reduced fluo­
rescence [58]. Since the mid-1980s the protein recognized by GB3 
has been characterized by Dr. J-p Ortonne's laboratory in Nice, 
France, and has been named BM600 and, more recently, nicein 
[21,56]. 
GB3 has not only been used extensively for the diagnosis and 
prenatal diagnosis of junctional EB [59] but has revealed a wide­
spread defect of basement membrane and a keratinocyte dysfunction 
in junctional EB [60] . Anti-kalinin antibodies showed the same 
reduced expressed injunctional EB tissue [61]. 19-DEJ-1 may be an 
even more useful antibody for the diagnosis of different forms of 
junctional EB, but also shows reduced staining in a significant.pro­
portion of patients with recessive dystrophic EB [62], questioning 
the relation between anchoring filaments (19-DEJ-1 antigen, ni­
cein/kalinin), the lamina densa (types IV and VII collagen), and 
anchoring fibrils (type VII collagen). It would be interesting to 
know whether nicein/kalinin, which is expressed early during fetal 
development and during epithelialization of wounds [63] has an 
inductive influence on other components on the dermal-epidermal 
junction, such as hemidesmosome plaques, which are structurally 
altered in fetuses affected with junctional EB [64] . 
Finally, if nicein/kalinin/epiligrin is a putative ligand for the 
integrin receptor a6p4 in vivo it would be logical to examine this 
integrin in junctional EB keratinocytes. A recent study showed pe­
ripheral detachment of basal keratinocytes from the underlying 
basement membrane, associated with interruption of staining for 
the P4 subunit [65]. 
CONCLUSION 
This article has illustrated how an essentially morphologic ap­
proach, expanded and strengthened by correlative immunochemi­
cal analysis, has pointed to abnormalities of anchoring fibrils and 
type VII collagen in different forms of dystrophic EB, and of hemi­
desmosomes and their associated protein nicein/kalinin/ epiligrin 
in junctional EB. Recent advances in molecular biology and genetics 
have provided powerful evidence for mutations in these candidate 
genes as the cause of EB in some families. It is possible that not all 
patients with these disorders will have demonstrable disorders in the 
COL7 At or nicein/kalinin genes and a search for further candidates 
will be required. It seems highly plausible that mutations of other 
genes encoding established or novel components of the BMZ will 
also emerge as the basis of heritable blistering disorders. 
Future work correlating structural changes in fibrils and fila­
ments with abnormalities in DNA or RNA should help to clarify 
aspects of gene function and regulation, and enhance our knowl­
edge of the molecular pathology of bullous diseases. 
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